Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine + nalbuphine or triamcinolone vs lidocaine alone for pain during intra-articular knee injection
TCTR20211028004Phase 3Recruiting
- Sponsor
- N/A
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine, nalbuphine, triamcinolone in knee osteoarthritis (OA), sponsored by N/A. Started Oct 2021; status: recruiting.
02
Drugs
lidocainenalbuphinetriamcinolone
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on TCTR20211028004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211028004.